SL STRATEGIES, LLC

Lobbying for PARTNER THERAPEUTICS · biotechnology company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $45,000.00 income · posted Nov 10, 2025

Lobbying activity 2

Health Issues

Issues related to rad/nuc preparedness and response; Pandemic All-Hazards Preparedness and Response

Budget/Appropriations

Fiscal Year 2026 HHS appropriations for rad/nuc preparedness and response, specifically within BARDA and the Strategic National Stockpile.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.